Regulating Lactation: Defining Key Players in the Lactogenic Process for the Development of an In Vitro Model of Drug Transfer into Breast Milk
Year: 2021
Type: dissertation
Abstract: The study of xenobiotic transfer into breast milk remains an unresolved and difficult task, as clinical trials involving the administration of drugs to breastfeeding mothers to measure milk levels mostly remain unethical and unsafe. Although prediction of drug excretion into milk using physiologically based pharmacokinetic (PBPK) modeling coupled with in vitro-in vivo extrapolation is becoming an important alternative, in vitro experimental approaches remain to be fully developed. This thesis attempted to enrich the knowledge required for the development of in vitro approaches and PBPK models of lactation in 4 domains: the identification of gene expression profiles of the lactating mammary gland; the elucidation of the role of ELF5 in ABCG2 expression; the 3D visualization of milk and vascular compartments of the lactating mammary gland and development of a microfluidic mammary gland-on-chip as an experimental platform in vitro; and the exploration of methotrexate mammary gland transport. First, a gene expression profile in the lactating mouse mammary gland was identified through GEO2R analysis of published microarray data, which was then used to examine hormone responses of the CIT3 mammary epithelial (MEC) line. Second, ELF5, an identified lactogenic marker, was found to be a transcription factor for ABCG2 expression, a transporter marker of the lactating mammary gland, upon prolactin stimulation in vitro. Third, the 3D imaging of the milk and vascular compartments of the lactating mouse mammary gland by 2-photon microscopy revealed dimensional characteristics of milk compartments interspersed by attenuated epithelia and a network of microvasculature. Further, a microfluidic chip was developed as an in vitro platform of the mammary gland, composed of poly(methylmethacrylate) pieces with channels accommodating media flow on either side of a porous membrane. Lastly, in order to gain mechanistic insight into the influx of methotrexate into MECs as a potential target pathway for riboflavin-associated reduction of methotrexate excretion into milk, folate receptor alpha (FRα) was tested for its capacity to mediate methotrexate influx into FRα-overexpressing HEK293 cells. A known methotrexate receptor highly upregulated in the lactating mammary gland, data reveal FRα to be a mediator of methotrexate influx into MECs, however riboflavin interference of methotrexate uptake was not detected.
Source: TSpace (University of Toronto)
Author: Workewych, Natalie Valentina
Institution: University of Toronto
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7005554667
